Members directory | Become a member | My DCVMN

Contact us

News

August 15, 2024

Panacea Biotec and ICMR initiate Phase III Clinical Trial of DengiAll

clinicaltrials Dengue

July 2, 2024

DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa”

Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect

June 28, 2024

Regulatory Working Group Workshop on Next-Generation Sequencing (NGS) technology

DCVMN achievements DCVMN Working Groups Vaccines & immunization

June 25, 2024

DCVMN at the Global Forum for Vaccine Sovereignty and Innovation

CEO DCVMN Advocacy Vaccines & immunization

June 10, 2024

24th DCVMN Annual General Meeting Report

DCVMN achievements Publication

June 7, 2024

2023 DCVMN International Annual Report

DCVMN achievements WeConnectToProtect

June 3, 2024

4th DCVMN Tech-Transfer Training

DCVMN achievements Workforce Training

June 2, 2024

DCVMN at the “Advancing Biomanufacturing Workforce Training for Global Health Equity” Advocacy Event

CEO DCVMN Advocacy Workforce Training

June 2, 2024

DCVMN CEO Attended a Private Session at the Permanent Mission of France to the UN in Geneva

CEO DCVMN Advocacy Sustainable Regional Manufacturing WeConnectToProtect

May 29, 2024

DCVMN Joint Statement at WHA77

DCVMN Advocacy Pandemic Preparedness Statement Vaccines & immunization

May 24, 2024

DCVMN Teamed Up with Leading Vaccine Experts and Manufacturers to Co-author an Article on the Pandemic Agreement

Article CEO DCVMN Advocacy DCVMNpartnerships Pandemic Preparedness

May 23, 2024

The Pandemic Agreement: A Bridge to Nowhere or North Star to Access and Global Health Security?

COVID-19 developingcountries GlobalHelath

Our sponsors

Our sponsors

Our sponsors

Our sponsors